{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:10:35Z","timestamp":1790061035836,"version":"4.0.1"},"reference-count":189,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biosensors"],"abstract":"<jats:p>Stroke is a widespread condition that causes 7 million deaths globally. Survivors suffer from a range of disabilities that affect their everyday life. It is a complex condition and there is a need to monitor the different signals that are associated with it. Stroke patients need to be rapidly diagnosed in the emergency department in order to allow the admission of the time-limited treatment of tissue plasminogen activator (tPA). Stroke diagnostics show the use of sophisticated technologies; however, they still contain limitations. The hidden information and technological advancements behind the utilization of biomarkers for stroke triaging are significant. Stroke biomarkers can revolutionize the way stroke patients are diagnosed, monitored, and how they recover. Different biomarkers indicate different cascades and exhibit unique expression patterns which are connected to certain pathologies in the human body. Over the past decades, B-type natriuretic peptide (BNP) and its derivative N-terminal fragment (NT-proBNP) have been increasingly investigated and highlighted as significant cardiovascular biomarkers. This work reviews the recent studies that have reported on the usefulness of BNP and NT-proBNP for stroke triaging. Their classification association is also presented, with increased mortality in stroke, correlation with cardioembolic stroke, and an indication of a second stroke recurrence. Moreover, recent scientific efforts conducted for the technological advancement of a bedside point-of-care (POC) device for BNP and NT-proBNP measurements are discussed. The conclusions presented in this review may hopefully assist in the major efforts that are currently being conducted in order to improve the care of stroke patients.<\/jats:p>","DOI":"10.3390\/bios10090107","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T09:56:58Z","timestamp":1598435818000},"page":"107","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["B-Type Natriuretic Peptide as a Significant Brain Biomarker for Stroke Triaging Using a Bedside Point-of-Care Monitoring Biosensor"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4119-6284","authenticated-orcid":false,"given":"Dorin","family":"Harpaz","sequence":"first","affiliation":[{"name":"School of Material Science &amp; Engineering, Nanyang Technology University, 50 Nanyang Avenue, Singapore 639798, Singapore"},{"name":"Department of Biotechnology Engineering, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond C. S.","family":"Seet","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, NUHS Tower Block, 1E Kent Ridge Road, Singapore 119228, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9697-3805","authenticated-orcid":false,"given":"Robert S.","family":"Marks","sequence":"additional","affiliation":[{"name":"Department of Biotechnology Engineering, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3546-7180","authenticated-orcid":false,"given":"Alfred I. Y.","family":"Tok","sequence":"additional","affiliation":[{"name":"School of Material Science &amp; Engineering, Nanyang Technology University, 50 Nanyang Avenue, Singapore 639798, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,8,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1474-4422(07)70031-5","article-title":"Preventing stroke: Saving lives around the world","volume":"6","author":"Strong","year":"2007","journal-title":"Lancet Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Rabinstein, A.A. (2020). Acute ischemic stroke. Neurological Emergencies: A Practical Approach, Springer International Publishing.","DOI":"10.1007\/978-3-030-28072-7"},{"key":"ref_3","unstructured":"American Heart Association and American Stroke Association Linking Policy (2020, June 01). Stroke. Available online: https:\/\/www.stroke.org\/en\/about-stroke\/types-of-stroke."},{"key":"ref_4","first-page":"1","article-title":"Stroke and Transient Ischemic Attack","volume":"Volume 6","author":"Maldonado","year":"2007","journal-title":"ACS Surgery: Principles and Practice"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/09638280802355072","article-title":"Recovery after stroke: A 1-year profile","volume":"31","author":"Horgan","year":"2009","journal-title":"Disabil. Rehabil."},{"key":"ref_6","unstructured":"Bhavna, J. (2015). Stroke Diagnostics and Therapeutics: Global Markets, BCC Research."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e007849","DOI":"10.1136\/bmjopen-2015-007849","article-title":"Systematic review of rehabilitation programmes initiated within 90 days of a transient ischaemic attack or \u2018minor\u2019stroke: A protocol","volume":"5","author":"Heron","year":"2015","journal-title":"BMJ Open"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(07)60150-0","article-title":"Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack","volume":"369","author":"Johnston","year":"2007","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1007\/s00415-019-09249-5","article-title":"Lifestyles correlate with stroke recurrence in Chinese inpatients with first-ever acute ischemic stroke","volume":"266","author":"Huang","year":"2019","journal-title":"J. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"MacKay-Lyons, M., Gubitz, G., Giacomantonio, N., Wightman, H., Marsters, D., Thompson, K., Blanchard, C., Eskes, G., and Thornton, M. (2010). Program of rehabilitative exercise and education to avert vascular events after non-disabling stroke or transient ischemic attack (PREVENT Trial): A multi-centred, randomised controlled trial. BMC Neurol., 10.","DOI":"10.1186\/1471-2377-10-122"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1161\/01.STR.0000223048.70103.F1","article-title":"Primary prevention of ischemic stroke: A guideline from the American Heart Association\/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline","volume":"37","author":"Goldstein","year":"2006","journal-title":"Stroke"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(05)67702-1","article-title":"Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study)","volume":"366","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrneurol.2010.36","article-title":"Ischemic stroke in the elderly: An overview of evidence","volume":"6","author":"Chen","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Warlow, C.P., van Gijn, J., Dennis, M., Wardlaw, J., Bamford, J., Hankey, G., Sandercock, P., Rinkle, G., Langhorne, P., and Sudlow, C. (2008). Stroke: Practical Management, Blackwell Publishing. [3rd ed.].","DOI":"10.1002\/9780470696361"},{"key":"ref_15","unstructured":"Allender, S., Scarborough, P., Peto, V., Rayner, M., Leal, J., Luengo-Fernandez, R., and Gray, A. (2008). European Cardiovascular Disease Statistics, European Heart Network."},{"key":"ref_16","unstructured":"National Audit Office, Department of Health (2005). Reducing Brain Damage: Faster Access to Better Stroke Care."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.STR.0000170700.45340.39","article-title":"Houston paramedic and emergency stroke treatment and outcomes study (HoPSTO)","volume":"36","author":"Alexandrov","year":"2005","journal-title":"Stroke"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/S0140-6736(12)60768-5","article-title":"The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): A randomised controlled trial","volume":"379","author":"Sandercock","year":"2012","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Kuhrij, L.S., Marang-van de Mheen, P.J., van den Berg-Vos, R.M., de Leeuw, F.-E., and Nederkoorn, P.J. (2019). Determinants of extended door-to-needle time in acute ischemic stroke and its influence on in-hospital mortality: Results of a nationwide Dutch clinical audit. BMC Neurol., 19.","DOI":"10.1186\/s12883-019-1512-2"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"National Institute of Neurological Disorders, and Stroke rt-PA Stroke Study Group (1995). Tissue Plasminogen Activator for Acute Ischemic Stroke. N. Engl. J. Med., 333, 1581\u20131588.","DOI":"10.1056\/NEJM199512143332401"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1161\/STROKEAHA.107.181486","article-title":"Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association\/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists","volume":"38","author":"Adams","year":"2007","journal-title":"Stroke"},{"key":"ref_23","first-page":"46","article-title":"Stroke patient workflow optimization","volume":"18","author":"Sukumaran","year":"2019","journal-title":"Endovasc Today"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1212\/WNL.0b013e31829e0fdd","article-title":"Prehospital stroke care: New prospects for treatment and clinical research","volume":"81","author":"Audebert","year":"2013","journal-title":"Neurology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1161\/STROKEAHA.107.487967","article-title":"Facilities available in European hospitals treating stroke patients","volume":"38","author":"Leys","year":"2007","journal-title":"Stroke"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e013101","DOI":"10.1161\/JAHA.119.013101","article-title":"Reasons for Prehospital Delay in Acute Ischemic Stroke","volume":"8","author":"Fladt","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Sharobeam, A., Jones, B., Walton-Sonda, D., and Lueck, C.J. (2020). Factors delaying intravenous thrombolytic therapy in acute ischaemic stroke: A systematic review of the literature. J. Neurol., 1\u201312.","DOI":"10.1007\/s00415-020-09803-6"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/imj.12204","article-title":"Minimising time to treatment: Targeted strategies to minimise time to thrombolysis for acute ischaemic stroke","volume":"43","author":"Tai","year":"2013","journal-title":"Intern. Med. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000054763","article-title":"Prehospital and in-hospital delays in acute stroke care","volume":"20","author":"Evenson","year":"2001","journal-title":"Neuroepidemiology"},{"key":"ref_30","first-page":"1","article-title":"Ischaemic stroke","volume":"5","author":"Campbell","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1001\/jama.292.15.1823","article-title":"Comparison of MRI and CT for detection of acute intracerebral hemorrhage","volume":"292","author":"Kidwell","year":"2004","journal-title":"JAMA"},{"key":"ref_32","unstructured":"Garrison, M.E., Chou, T.M., Hyde, G.M., and Schaer, A.K. (2013). Methods and Systems for Treatment of Acute Ischemic Stroke. (US20130281788A1), U.S. Patent."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S1474-4422(10)70251-9","article-title":"Aetiological diagnosis of ischaemic stroke in young adults","volume":"9","author":"Ferro","year":"2010","journal-title":"Lancet Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/01.STR.20.7.864","article-title":"Measurements of acute cerebral infarction: A clinical examination scale","volume":"20","author":"Brott","year":"1989","journal-title":"Stroke"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/archneur.1989.00520420080026","article-title":"Interrater reliability of the NIH stroke scale","volume":"46","author":"Goldstein","year":"1989","journal-title":"Arch. Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41598-019-57316-8","article-title":"NIHSS is not enough for cognitive screening in acute stroke: A cross-sectional, retrospective study","volume":"10","author":"Tamar","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/01.STR.0000204041.13466.4c","article-title":"Distinguishing between stroke and mimic at the bedside: The brain attack study","volume":"37","author":"Hand","year":"2006","journal-title":"Stroke"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jstrokecerebrovasdis.2007.09.008","article-title":"Identification of nonischemic stroke mimics among 411 code strokes at the University of California, San Diego, Stroke Center","volume":"17","author":"Hemmen","year":"2008","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1212\/01.wnl.0000196478.77152.fc","article-title":"IV tissue plasminogen activator use in acute stroke: Experience from a statewide registry","volume":"66","author":"Deng","year":"2006","journal-title":"Neurology"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Watkins, C.L., Leathley, M.J., Jones, S.P., Ford, G.A., Quinn, T., and Sutton, C.J. (2013). Training emergency services\u2019 dispatchers to recognise stroke: An interrupted time-series analysis. BMC Health Serv. Res., 13.","DOI":"10.1186\/1472-6963-13-318"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/JNN.0000000000000474","article-title":"Validity and Reliability of the Responses to Ischemic Stroke Symptoms Questionnaire","volume":"51","author":"Beal","year":"2019","journal-title":"J. Neurosci. Nurs."},{"key":"ref_42","unstructured":"(2020, June 01). Stroke Prevention and Care in France: Report for the Minister of Health and Sport, Available online: https:\/\/www1.health.gov.au\/internet\/main\/publishing.nsf\/Content\/For+Health+Professionals-1."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3109\/09638288.2015.1059496","article-title":"A systematic review of studies investigating the care of stroke survivors in long-term care facilities","volume":"38","author":"Teo","year":"2016","journal-title":"Disabil. Rehabil."},{"key":"ref_44","first-page":"19","article-title":"Post-Stroke Follow-Up at the Rehabilitation Center Outpatient Clinic","volume":"28","author":"Greenberg","year":"2004","journal-title":"Sat"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1161\/01.STR.0000242290.01174.9e","article-title":"Association of serial biochemical markers with acute ischemic stroke: The National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study","volume":"37","author":"Jauch","year":"2006","journal-title":"Stroke"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jemermed.2010.02.025","article-title":"Discriminative capacity of biomarkers for acute stroke in the emergency department","volume":"41","author":"Glickman","year":"2011","journal-title":"J. Emerg. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s11940-012-0196-3","article-title":"Strategies to augment recovery after stroke","volume":"14","author":"Chollet","year":"2012","journal-title":"Curr. Treat. Options Neurol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuint.2017.01.005","article-title":"Stroke biomarkers in clinical practice: A critical appraisal","volume":"107","author":"Ng","year":"2017","journal-title":"Neurochem. Int."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s12975-019-00762-3","article-title":"Biomarker Application for Precision Medicine in Stroke","volume":"11","author":"Simpkins","year":"2020","journal-title":"Transl. Stroke Res."},{"key":"ref_50","first-page":"w20125","article-title":"Biomarkers in cardiovascular medicine: Towards precision medicine","volume":"149","author":"Twerenbold","year":"2019","journal-title":"Swiss Med. Wkly."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Harpaz, D., Eltzov, E., Seet, R., Marks, R.S., and Tok, A.I.Y. (2017). Point-of-care-testing in acute stroke management: An unmet need ripe for technological harvest. Biosensors, 7.","DOI":"10.3390\/bios7030030"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41582-019-0181-5","article-title":"Stroke prediction and the future of prognosis research","volume":"15","author":"Quinn","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/bja\/aer338","article-title":"Neurological biomarkers in the perioperative period","volume":"107","author":"Cata","year":"2011","journal-title":"Br. J. Anaesth."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1161\/STROKEAHA.111.618835","article-title":"Oxidative damage in ischemic stroke revealed using multiple biomarkers","volume":"42","author":"Seet","year":"2011","journal-title":"Stroke"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/STROKEAHA.108.516377","article-title":"Clinical usefulness of a biomarker-based diagnostic test for acute stroke: The Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study","volume":"40","author":"Laskowitz","year":"2009","journal-title":"Stroke"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/cns.12127","article-title":"Biomarkers for the clinical differential diagnosis in traumatic brain injury\u2014A systematic review","volume":"19","author":"Yokobori","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.earlhumdev.2014.06.010","article-title":"Serum biomarkers to evaluate the integrity of the neurovascular unit","volume":"90","author":"Mir","year":"2014","journal-title":"Early Hum. Dev."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Peplow, P.V., Martinez, B., and Dambinova, S.A. (2020). Stroke Biomarkers, Humana.","DOI":"10.1007\/978-1-4939-9682-7"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s12017-019-08530-0","article-title":"Blood Biomarkers for Stroke Diagnosis and Management","volume":"21","author":"Jickling","year":"2019","journal-title":"Neuromol. Med."},{"key":"ref_60","unstructured":"Sharp, F., and Jickling, G.C. (2019). Biomarkers for the Diagnosis of Lacunar Stroke. (US10196690B2), U.S. Patent."},{"key":"ref_61","unstructured":"Ford, B.D., and Ford, G. (2019). Biomarkers for Stroke. (US20190004065A1), U.S. Patent."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.brainres.2018.08.012","article-title":"Identification of novel blood biomarker panels to detect ischemic stroke in patients and their responsiveness to therapeutic intervention","volume":"1698","author":"Augello","year":"2018","journal-title":"Brain Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/10408363.2018.1461190","article-title":"Blood biomarkers in ischemic stroke: Potential role and challenges in clinical practice and research","volume":"55","author":"Makris","year":"2018","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Peplow, P.V., Dambinova, S.A., Gennarelli, T.A., and Martinez, B. (2017). Resolving Difficult Case Scenarios by Incorporating Stroke Biomarkers in Clinical Decision-making. Acute Brain Impairment: Scientidic Discoveries and Translational Research, Royal Society of Chemistry.","DOI":"10.1039\/9781788012539"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1700007","DOI":"10.1002\/prca.201700007","article-title":"Blood-based protein biomarkers for stroke differentiation: A systematic review","volume":"11","author":"Misra","year":"2017","journal-title":"Proteom. Clin. Appl."},{"key":"ref_66","unstructured":"LaMont, J., Mc Connell, I., and Fitzgerald, P. (2017). Biomarker-Based Methods and Biochips for Aiding the Diagnosis of Stroke. (15\/457,297), U.S. Patent."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41582-020-0350-6","article-title":"Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke","volume":"16","author":"Montaner","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2147\/CIA.S233909","article-title":"The Role of Selected Pro-Inflammatory Cytokines in Pathogenesis of Ischemic Stroke","volume":"15","author":"Pawluk","year":"2020","journal-title":"Clin. Interv. Aging"},{"key":"ref_69","unstructured":"Liu, K.J., Liu, W., Timmins, G., and Pan, R. (2020). Blood Biomarker for Early Blood Brain Barrier Disruption in Ischemic Stroke. (US10591491B1), U.S. Patent."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.advms.2019.06.001","article-title":"The potential role of inflammation in cryptogenic stroke","volume":"64","author":"Banach","year":"2019","journal-title":"Adv. Med. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Lee, N.S., and Daniels, L.B. (2016). Natriuretic peptide use in screening in the community. Cardiac Biomarkers, Springer.","DOI":"10.1007\/978-3-319-42982-3_15"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10741-014-9451-x","article-title":"B-type natriuretic peptide-guided therapy: A systematic review","volume":"19","author":"Balion","year":"2014","journal-title":"Heart Fail. Rev."},{"key":"ref_73","unstructured":"Schisler, J.C., Lang, C.H., and Willis, M.S. (2017). Chapter 1\u2014Cardiac natriuretic peptides. Endocrinology of the Heart in Health and Disease, Academic Press."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1172\/JCI115146","article-title":"Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide","volume":"87","author":"Mukoyama","year":"1991","journal-title":"J. Clin. Investig."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3389\/fphys.2018.00692","article-title":"Brain Natriuretic Peptide and Its Biochemical, Analytical, and Clinical Issues in Heart Failure: A Narrative Review","volume":"9","author":"Fu","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1515\/CCLM.2008.295","article-title":"Biochemistry of B-type natriuretic peptide\u2013where are we now?","volume":"46","author":"Mair","year":"2008","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ahj.2004.03.014","article-title":"A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunction","volume":"148","author":"Atisha","year":"2004","journal-title":"Am. Heart J."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2362.1974.tb00405.x","article-title":"Isolation of a tridecapeptide from natriuretic fractions of bovine posterior pituitary","volume":"4","author":"Sedlakova","year":"1974","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1111\/j.1440-1681.1995.tb02874.x","article-title":"Preparation of a monoclonal antibody against mouse brain natriuretic peptide (BNP) and tissue distribution of BNP in mice","volume":"22","author":"Nakagawa","year":"1995","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1006\/bbrc.1995.2410","article-title":"The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma","volume":"214","author":"Hunt","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0195-668X(03)00476-7","article-title":"Clinical applications of B-type natriuretic peptide (BNP) testing","volume":"24","author":"Cowie","year":"2003","journal-title":"Eur. Heart J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3181\/00379727-170-41408","article-title":"Atrial natriuretic factor of the rat heart. Studies on isolation and properties","volume":"170","year":"1982","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0014-5793(90)80043-I","article-title":"Isolation and sequence determination of human brain natriuretic peptide in human atrium","volume":"259","author":"Kambayashi","year":"1990","journal-title":"FEBS Let."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0006-291X(90)92081-A","article-title":"Isolation and identification of human brain natriuretic peptides in cardiac atrium","volume":"167","author":"Hino","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1373\/clinchem.2004.039891","article-title":"Single assay for amino-terminal fragments of cardiac A-and B-type natriuretic peptides","volume":"51","author":"Ruskoaho","year":"2005","journal-title":"Clin. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ejheart.2005.06.003","article-title":"Clinical deterioration in established heart failure: What is the value of BNP and weight gain in aiding diagnosis?","volume":"7","author":"Lewin","year":"2005","journal-title":"Eur. J. Heart Failure"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0006-291X(84)91077-5","article-title":"Purification and complete amino acid sequence of \u03b1-human atrial natriuretic polypeptide (\u03b1-hANP)","volume":"118","author":"Kangawa","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0006-291X(89)92126-8","article-title":"Isolation and sequence determination of rat cardiac natriuretic peptide","volume":"163","author":"Kambayashi","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.abb.2006.03.028","article-title":"The precursor to B-type natriuretic peptide is an O-linked glycoprotein","volume":"451","author":"Schellenberger","year":"2006","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0006-291X(87)90515-8","article-title":"Identification of alpha atrial natriuretic peptide and in porcine brain","volume":"149","author":"Ueda","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/332078a0","article-title":"A new natriuretic peptide in porcine brain","volume":"332","author":"Sudoh","year":"1988","journal-title":"Nature"},{"key":"ref_92","first-page":"75","article-title":"A basic guide to understanding plasma B-type natriuretic peptide in the diagnosis of congestive heart failure","volume":"16","author":"Kreiger","year":"2007","journal-title":"Medsurg Nurs."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/qjmed\/hcn080","article-title":"Differential diagnosis of acute dyspnea: The value of B natriuretic peptides in the emergency department","volume":"101","author":"Ray","year":"2008","journal-title":"QJM Int. J. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1053\/j.jvca.2010.11.001","article-title":"The year in cardiothoracic and vascular anesthesia: Selected highlights from 2010","volume":"25","author":"Andritsos","year":"2011","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_95","first-page":"25","article-title":"Recent developments in the management of heart failure","volume":"256","author":"Cowie","year":"2012","journal-title":"Practitioner"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10741-014-9440-0","article-title":"A systematic review of BNP and NT-proBNP in the management of heart failure: Overview and methods","volume":"19","author":"Oremus","year":"2014","journal-title":"Heart Fail. Rev."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1212\/01.wnl.0000436937.32410.32","article-title":"B-type natriuretic peptides and mortality after stroke","volume":"81","author":"Giralt","year":"2013","journal-title":"Neurology"},{"key":"ref_98","first-page":"1023","article-title":"Diagnosis and treatment of acute ischemic stroke","volume":"65","author":"Shibazaki","year":"2013","journal-title":"Brain Nerve"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1212\/01.wnl.0000436949.75473.79","article-title":"Predicting stroke mortality","volume":"81","author":"Jickling","year":"2013","journal-title":"Neurology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000351777","article-title":"Brain Natriuretic Peptide on Admission as a Biological Marker of Long-Term Mortality in Ischemic Stroke Survivors","volume":"70","author":"Shibazaki","year":"2013","journal-title":"Eur. Neurol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.2169\/internalmedicine.51.8027","article-title":"The prognostic value of combined NT-pro-BNP levels and NIHSS scores in patients with acute ischemic stroke","volume":"51","author":"Chen","year":"2012","journal-title":"Intern. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000341858","article-title":"Brain Natriuretic Peptide Is Associated with Worsening and Mortality in Acute Stroke Patients but Adds No Prognostic Value to Clinical Predictors of Outcome","volume":"34","author":"Montaner","year":"2012","journal-title":"Cerebrovasc. Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"994","DOI":"10.12669\/pjms.344.15432","article-title":"Effects of serum N-terminal pro B-type natriuretic peptide and D-dimer levels on patients with acute ischemic stroke","volume":"34","author":"Li","year":"2018","journal-title":"Pak. J. Med Sci."},{"key":"ref_104","unstructured":"Hess, G., Horsch, A., and Zdunek, D. (2018). Troponin and Bnp Based Diagnosis of Risk Patients and Cause of Stroke. (US20180196066A1), U.S. Patent."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1212\/WNL.0000000000003937","article-title":"Copeptin and NT-proBNP for prediction of all-cause and cardiovascular death in ischemic stroke","volume":"88","author":"Tu","year":"2017","journal-title":"Neurology"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.5114\/amsad.2016.59751","article-title":"Levels of brain natriuretic peptide as a marker for the diagnosis and prognosis of acute ischemic stroke","volume":"1","author":"Sayan","year":"2016","journal-title":"Arch. Med. Sci. Atheroscler. Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000381218","article-title":"Role of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and inteleukin-6 in predicting a poor outcome after a stroke","volume":"22","author":"Bunevicius","year":"2015","journal-title":"Neuroimmunomodulation"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1161\/STROKEAHA.118.023218","article-title":"NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and the Risk of Stroke: Results from the BiomarCaRE Consortium","volume":"50","author":"Veronesi","year":"2019","journal-title":"Stroke"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1159\/000210432","article-title":"Classification of stroke subtypes","volume":"27","author":"Amarenco","year":"2009","journal-title":"Cerebrovasc. Dis."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11936-019-0786-4","article-title":"Cryptogenic Stroke: Diagnostic Workup and Management","volume":"21","author":"Flood","year":"2019","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1161\/01.STR.30.12.2513","article-title":"Ischemic stroke subtypes: A population-based study of incidence and risk factors","volume":"30","author":"Petty","year":"1999","journal-title":"Stroke"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1161\/01.STR.21.3.375","article-title":"Are hypertension or cardiac embolism likely causes of lacunar infarction?","volume":"21","author":"Lodder","year":"1990","journal-title":"Stroke"},{"key":"ref_113","first-page":"2559","article-title":"Risk Factors, Outcome, and Treatment in Subtypes of Ischemic Stroke","volume":"32","author":"Grau","year":"2001","journal-title":"Ger. Stroke Data Bank"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1161\/01.STR.31.5.1081","article-title":"Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography","volume":"31","author":"Lee","year":"2000","journal-title":"Stroke"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1161\/str.36.4.902","article-title":"Editorial comment\u2014Time to burn the TOAST","volume":"36","author":"Landau","year":"2005","journal-title":"Stroke"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/hrt.2004.052241","article-title":"Patent foramen ovale and the risk of stroke: Smoking gun guilty by association?","volume":"91","author":"Amarenco","year":"2005","journal-title":"Heart"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.02.014","article-title":"Predicting Cardioembolic Stroke with the B-Type Natriuretic Peptide Test: A Systematic Review and Meta-analysis","volume":"23","author":"Yang","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1161\/STROKEAHA.114.008311","article-title":"B-Type Natriuretic Peptides Help in Cardioembolic Stroke Diagnosis","volume":"46","author":"Llombart","year":"2015","journal-title":"Stroke"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.06.006","article-title":"Plasma Brain Natriuretic Peptide is a Marker of Prognostic Functional Outcome in Non\u2013Cardioembolic Infarction","volume":"24","author":"Kawase","year":"2015","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ajem.2015.01.013","article-title":"Validation of the use of B-type natriuretic peptide point-of-care test platform in preliminary recognition of cardioembolic stroke patients in the ED","volume":"33","author":"Wu","year":"2015","journal-title":"Am. J. Emerg. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.09.025","article-title":"Association of Plasma Brain Natriuretic Peptide Levels in Acute Ischemic Stroke Subtypes and Outcome","volume":"24","author":"Chaudhuri","year":"2015","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_123","first-page":"188","article-title":"Could pro-BNP, uric acid, bilirubin, albumin and transferrin be used in making the distinction between stroke subtypes?","volume":"51","author":"Cojocaru","year":"2013","journal-title":"Rom. J. Intern. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.clineuro.2014.04.033","article-title":"Experiences and the use of BNP POCT platform on suspected ischemic stroke patients in the emergency department setting","volume":"123","author":"Wu","year":"2014","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.01.012","article-title":"The diagnostic value of N-terminal pro-brain natriuretic peptide in differentiating cardioembolic ischemic stroke","volume":"22","author":"Hajsadeghi","year":"2013","journal-title":"J. Stroke Cerebrovasc. Dis. Off. J. Natl. Stroke Assoc."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/ene.12411","article-title":"B-type natriuretic peptide predicts stroke of presumable cardioembolic origin in addition to coronary artery calcification","volume":"21","author":"Kara","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.08.003","article-title":"Brain natriuretic peptide in acute ischemic stroke","volume":"23","author":"Maruyama","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis. Off. J. Natl. Stroke Assoc."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4103\/0972-2327.132670","article-title":"Experiences and the use of BNP POCT platform on suspected stroke patients by a Chinese emergency department","volume":"17","author":"Qihong","year":"2014","journal-title":"Ann. Indian Acad. Neurol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000342887","article-title":"Brain natriuretic peptide as a predictor of cardioembolism in acute ischemic stroke patients: Brain natriuretic peptide stroke prospective study","volume":"69","author":"Sakai","year":"2013","journal-title":"Eur. Neurol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2169\/internalmedicine.48.1475","article-title":"Plasma brain natriuretic peptide can be a biological marker to distinguish cardioembolic stroke from other stroke types in acute ischemic stroke","volume":"48","author":"Shibazaki","year":"2009","journal-title":"Intern. Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jns.2015.11.014","article-title":"Impact of BNP on cryptogenic stroke without potential embolic sources on transesophageal echocardiography","volume":"359","author":"Ueno","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1007\/s00380-019-01345-w","article-title":"Direct comparison of prognostic ability of cardiac biomarkers for cardiogenic stroke and clinical outcome in patients with stroke","volume":"34","author":"Otaki","year":"2019","journal-title":"Heart Vessel."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1080\/00207454.2017.1408612","article-title":"Detection of cardioembolic stroke with B-type natriuretic peptide or N-terminal pro-BNP: A comparative diagnostic meta-analysis","volume":"128","author":"Bai","year":"2018","journal-title":"Int. J. Neurosci."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"597570","DOI":"10.1155\/2015\/597570","article-title":"Difference in the prognostic significance of N-terminal pro-B-type natriuretic peptide between cardioembolic and noncardioembolic ischemic strokes","volume":"2015","author":"Lee","year":"2015","journal-title":"Dis. Markers"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1253\/circj.CJ-17-1124","article-title":"Ability of B-Type Natriuretic Peptide Testing to Predict Cardioembolic Stroke in the General Population\u2015Comparisons with C-Reactive Protein and Urinary Albumin\u2015","volume":"82","author":"Nakamura","year":"2018","journal-title":"Circ. J."},{"key":"ref_136","first-page":"44","article-title":"The value of using B-type natriuretic peptide and D-dimer in preliminary recognition of cardioembolic stroke patients","volume":"34","author":"Zhixin","year":"2018","journal-title":"J. Pract. Med."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"P1.051","DOI":"10.1212\/WNL.84.14_supplement.P1.051","article-title":"N-terminal pro-B-type natriuretic peptide predicts long-term mortality but not stroke recurrence in acute ischemic stroke patients with a cardioembolic source (P1. 051)","volume":"84","author":"Lee","year":"2015","journal-title":"Neurology"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.02.003","article-title":"Brain natriuretic peptide and particular left ventricle segment asynergy associated with cardioembolic stroke from old myocardial infarction","volume":"25","author":"Hosomi","year":"2016","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s41983-019-0102-y","article-title":"Cardio embolic stroke and blood biomarkers: Diagnosis and predictors of short-term outcome","volume":"55","author":"Mohamed","year":"2019","journal-title":"Egypt. J. Neurol. Psychiatry Neurosurg."},{"key":"ref_140","first-page":"95","article-title":"Ability of NT-pro-BNP to Diagnose Cardioembolic Etiology in Patients with Acute Ischemic Stroke","volume":"62","author":"Okada","year":"2016","journal-title":"Osaka City Med. J."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1071-9164(00)90010-1","article-title":"Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation","volume":"6","author":"Inoue","year":"2000","journal-title":"J. Card Fail."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clineuro.2014.09.028","article-title":"Brain natriuretic peptide level on admission predicts recurrent stroke after discharge in stroke survivors with atrial fibrillation","volume":"127","author":"Shibazaki","year":"2014","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.06.003","article-title":"Plasma Brain Natriuretic Peptide as a Predictive Marker of Early Recurrent Stroke in Cardioembolic Stroke Patients","volume":"23","author":"Shibazaki","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.3923\/pjbs.2013.1393.1397","article-title":"ABCD2 score and BNP level in patients with TIA and cerebral stroke","volume":"16","author":"Mortezabeigi","year":"2013","journal-title":"Pak. J. Biol. Sci."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijcard.2019.06.056","article-title":"NT-pro-BNP: A novel predictor of stroke risk after transient ischemic attack","volume":"298","author":"Hervella","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.biotechadv.2016.01.005","article-title":"Point-of-care diagnostics for niche applications","volume":"34","author":"Cummins","year":"2016","journal-title":"Biotechnol. Adv."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.3390\/s100504558","article-title":"Glucose biosensors: An overview of use in clinical practice","volume":"10","author":"Yoo","year":"2010","journal-title":"Sensors"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2741\/S357","article-title":"Point-of-care biosensor system","volume":"5","author":"Vasan","year":"2013","journal-title":"Front. Biosci."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"C98","DOI":"10.12968\/hmed.2016.77.7.C98","article-title":"Enzyme-linked immunosorbent assay (ELISA): The basics","volume":"77","author":"Shah","year":"2016","journal-title":"Br. J. Hosp. Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/bmj.322.7297.1285","article-title":"Point of care testing","volume":"322","author":"Price","year":"2001","journal-title":"BMJ Br. Med J."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1473-3099(13)70250-0","article-title":"Diagnostic point-of-care tests in resource-limited settings","volume":"14","author":"Drain","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref_152","first-page":"121","article-title":"Electrochemical biosensors: Recommended definitions and classification","volume":"16","author":"Thevenot","year":"2001","journal-title":"Biosens. Bioelectron."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1586\/erm.11.38","article-title":"Biosensors based on combined optical and electrochemical transduction for molecular diagnostics","volume":"11","author":"Eltzov","year":"2011","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00216-010-4084-y","article-title":"Whole-cell aquatic biosensors","volume":"400","author":"Eltzov","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_155","first-page":"155","article-title":"Existing and Emerging Technologies for Point-of-Care Testing","volume":"35","author":"Price","year":"2014","journal-title":"Clin. Biochem. Rev."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1039\/c2lc21204h","article-title":"Commercialization of microfluidic point-of-care diagnostic devices","volume":"12","author":"Chin","year":"2012","journal-title":"Lab. Chip"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Paul, S. (2019). Biomedical Engineering and Its Applications in Healthcare, Springer.","DOI":"10.1007\/978-981-13-3705-5"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12245-010-0177-9","article-title":"Time-critical neurological emergencies: The unfulfilled role for point-of-care testing","volume":"3","author":"McMullan","year":"2010","journal-title":"Int. J. Emerg. Med."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1186\/s13054-014-0692-9","article-title":"Point-of-care testing in the overcrowded emergency department\u2014Can it make a difference?","volume":"18","author":"Rooney","year":"2014","journal-title":"Crit. Care"},{"key":"ref_160","first-page":"263","article-title":"Rapid Point-of-Care-Tests for Stroke Monitoring","volume":"56","author":"Harpaz","year":"2019","journal-title":"Org. Bioelectron. Life Sci. Healthc."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1373\/clinchem.2010.148775","article-title":"Characterization of Molecular Forms of N-Terminal B-Type Natriuretic Peptide in Vitro","volume":"56","author":"Moilanen","year":"2010","journal-title":"Clin. Chem."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.amjcard.2007.11.013","article-title":"Amino-Terminal Pro\u2013B-Type Natriuretic Peptide: Analytic Considerations","volume":"101","author":"Collinson","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1373\/clinchem.2004.044594","article-title":"Quality Specifications for B-Type Natriuretic Peptide Assays","volume":"51","author":"Apple","year":"2005","journal-title":"Clin. Chem."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1373\/clinchem.2003.024760","article-title":"Diagnostic Accuracy and Prognostic Relevance of the Measurement of Cardiac Natriuretic Peptides: A Review","volume":"50","author":"Clerico","year":"2004","journal-title":"Clin. Chem."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/00365510500236242","article-title":"Standardization of Cardiac Markers","volume":"65","author":"Apple","year":"2005","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"165","DOI":"10.24190\/ISSN2564-615X\/2017\/02.09","article-title":"Electrochemical impedimetric detection of stroke biomarker NT-proBNP using disposable screen-printed gold electrodes","volume":"1","author":"Sinawang","year":"2017","journal-title":"Eurobiotech. J."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Harpaz, D., Koh, B., Marks, R.S., Seet, R., Abdulhalim, I., and Tok, A.I.Y. (2019). Point-of-Care surface plasmon resonance biosensor for stroke biomarkers NT-proBNP and S100\u03b2 using a functionalized gold chip with specific antibody. Sensors, 19.","DOI":"10.3390\/s19112533"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"120792","DOI":"10.1016\/j.talanta.2020.120792","article-title":"Functionalized silicon dioxide self-referenced plasmonic chip as point-of-care biosensor for stroke biomarkers NT-proBNP and S100\u03b2","volume":"212","author":"Harpaz","year":"2020","journal-title":"Talanta"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0196-9781(97)00245-3","article-title":"The role of the circulation in processing pro-brain natriuretic peptide (proBNP) to amino-terminal BNP and BNP-32","volume":"18","author":"Hunt","year":"1997","journal-title":"Peptides"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1373\/clinchem.2004.034272","article-title":"Biochemistry of pro-B-type natriuretic peptide-derived peptides: The endocrine heart revisited","volume":"50","author":"Goetze","year":"2004","journal-title":"Clin. Chem."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1373\/clinchem.2007.100040","article-title":"Immunodetection of glycosylated NT-proBNP circulating in human blood","volume":"54","author":"Seferian","year":"2008","journal-title":"Clin. Chem."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1373\/clinchem.2004.032490","article-title":"Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A-and B-type natriuretic peptides","volume":"50","author":"Magga","year":"2004","journal-title":"Clin. Chem."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/cs0960373","article-title":"An immunoluminometric assay for N-terminal pro-brain natriuretic peptide: Development of a test for left ventricular dysfunction","volume":"96","author":"Hughes","year":"1999","journal-title":"Clin. Sci."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00365519909168341","article-title":"Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit","volume":"59","author":"Karl","year":"1999","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1071-9164(00)90015-0","article-title":"Plasma amino-terminal pro-brain natriuretic peptide: A novel approach to the diagnosis of cardiac dysfunction","volume":"6","author":"Campbell","year":"2000","journal-title":"J. Card. Fail."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1042\/CS20040087","article-title":"N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction","volume":"107","author":"Squire","year":"2004","journal-title":"Clin. Sci."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/clinchem\/48.7.1035","article-title":"Quantification of pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing","volume":"48","author":"Goetze","year":"2002","journal-title":"Clin. Chem."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1373\/49.6.976","article-title":"Comparison of the Biomedica NT-proBNP enzyme immunoassay and the Roche NT-proBNP chemiluminescence immunoassay: Implications for the prediction of symptomatic and asymptomatic structural heart disease","volume":"49","author":"Mueller","year":"2003","journal-title":"Clin. Chem."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1373\/clinchem.2003.028316","article-title":"Natriuretic peptides as markers of mild forms of left ventricular dysfunction: Effects of assays on diagnostic performance of markers","volume":"50","author":"Ludwig","year":"2004","journal-title":"Clin. Chem."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1373\/clinchem.2007.100545","article-title":"Novel immunoassay for quantification of brain natriuretic peptide and its precursor in human blood","volume":"54","author":"Tamm","year":"2008","journal-title":"Clin. Chem."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"14155","DOI":"10.1021\/bi0607047","article-title":"Interactions of two monoclonal antibodies with BNP: High resolution epitope mapping using fluorescence correlation spectroscopy","volume":"45","author":"Tetin","year":"2006","journal-title":"Biochemistry"},{"key":"ref_182","unstructured":"Balion, C., Don-Wauchope, A., Hill, S., Santaguida, P.L., Booth, R., Brown, J.A., Oremus, M., Ali, U., Bustamam, A., and Sohel, N. (2013). Use of Natriuretic Peptide Measurement in the Management of Heart Failure."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10741-016-9544-9","article-title":"A review on B-type natriuretic peptide monitoring: Assays and biosensors","volume":"21","author":"Maalouf","year":"2016","journal-title":"Heart Fail. Rev."},{"key":"ref_184","first-page":"446","article-title":"Plasma brain natriuretic peptide measured by fully-automated immunoassay and by immunoradiometric assay compared","volume":"39","author":"Giannessi","year":"2001","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF03347297","article-title":"Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure","volume":"21","author":"Clerico","year":"1998","journal-title":"J. Endocrinol. Investig."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.plabm.2015.04.002","article-title":"Analytical evaluation of a BNP assay on the new point-of-care platform respons\u00ae IQ","volume":"2","author":"Fellner","year":"2015","journal-title":"Pract. Lab. Med."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1536\/ihj.53.320","article-title":"Comparison of analytical performance of two single-step measurement devices of B-type natriuretic peptide","volume":"53","author":"Ishida","year":"2012","journal-title":"Int. Heart J."},{"key":"ref_188","first-page":"135","article-title":"Introduction of Rapidtip BNP and Rapidpia\u2014A clinical significance of rapid measurement BNP for home medicine care","volume":"36","author":"Yasukawa","year":"2009","journal-title":"Gan Kagaku Ryoho. Cancer Chemother."},{"key":"ref_189","unstructured":"Denny, N., Lasserson, D., Price, P.C., Heneghan, C., Thompson, M., and Pl\u00fcddemann, A. (2011). Diagnostic Technology: Point of Care B-Type Natriuretic Peptide Testing, Primary Care Diagnostic Horizon Scanning Centre Oxford. Available online: https:\/\/www.community.healthcare.mic.nihr.ac.uk\/files\/reports-and-resources\/horizon-scanning-report0019-bnp.pdf."}],"container-title":["Biosensors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6374\/10\/9\/107\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:07:11Z","timestamp":1760177231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6374\/10\/9\/107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,26]]},"references-count":189,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["bios10090107"],"URL":"https:\/\/doi.org\/10.3390\/bios10090107","relation":{},"ISSN":["2079-6374"],"issn-type":[{"value":"2079-6374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,26]]}}}